Published in Am J Gastroenterol on March 22, 2007
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Capsule endoscopy in nonresponsive celiac disease. Gastrointest Endosc (2011) 1.54
Classification and management of refractory coeliac disease. Gut (2010) 1.48
Small bowel capsule endoscopy in 2007: indications, risks and limitations. World J Gastroenterol (2007) 1.44
Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients (2013) 1.29
Evaluation of Cladribine treatment in refractory celiac disease type II. World J Gastroenterol (2011) 1.04
Celiac disease and autoimmunity in the gut and elsewhere. Gastroenterol Clin North Am (2008) 0.99
Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances. Clin Exp Gastroenterol (2011) 0.97
Current status of device-assisted enteroscopy: Technical matters, indication, limits and complications. World J Gastrointest Endosc (2012) 0.91
Update on the diagnosis and management of refractory coeliac disease. Gastroenterol Res Pract (2013) 0.88
From Capsule Endoscopy to Balloon-Assisted Deep Enteroscopy: Exploring Small-Bowel Endoscopic Imaging. Gastroenterol Hepatol (N Y) (2015) 0.87
Pearls and pitfalls in the diagnosis of adult celiac disease. Can J Gastroenterol (2008) 0.86
Double balloon endoscopy associated pancreatitis: a description of six cases. World J Gastroenterol (2008) 0.86
A case of enteropathy-type T-cell lymphoma diagnosed by small bowel enteroscopy: a perspective on imaging-enhanced endoscopy. Gut Liver (2012) 0.83
Comparison of double balloon enteroscopy in adults and children. World J Gastroenterol (2013) 0.82
Double-balloon endoscopy depicts diminutive small bowel lesions in gastrointestinal lymphoma. Dig Dis Sci (2009) 0.82
Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol (2015) 0.80
Is enteroscopy necessary for diagnosis of celiac disease? World J Gastroenterol (2012) 0.80
Recent advances in small bowel diseases: Part II. World J Gastroenterol (2012) 0.78
Diagnosis and management of mid-gastrointestinal bleeding by double-balloon endoscopy. Therap Adv Gastroenterol (2009) 0.75
Challenges in the diagnosis of enteropathy-associated T cell lymphoma. Can J Gastroenterol (2013) 0.75
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet (2007) 8.50
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
A prospective study comparing video capsule endoscopy with double-balloon enteroscopy in patients with obscure gastrointestinal bleeding. Am J Gastroenterol (2006) 3.27
Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet (2008) 3.11
Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ (2010) 2.94
Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet (2009) 2.15
Sustained clinical benefit and tolerability of methotrexate monotherapy after thiopurine therapy in patients with Crohn's disease. Clin Gastroenterol Hepatol (2013) 2.00
Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA (2010) 1.99
Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: a retrospective study comparing the performance of the updated AGA and BSG guidelines. Inflamm Bowel Dis (2013) 1.96
Receptor conversion in distant breast cancer metastases. Breast Cancer Res (2010) 1.85
Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease. Hum Mol Genet (2010) 1.78
Frequent delay of coeliac disease diagnosis in symptomatic patients with type 1 diabetes mellitus: clinical and genetic characteristics. Eur J Intern Med (2013) 1.59
Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut (2012) 1.52
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis. Dig Liver Dis (2010) 1.43
The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impact. Gastrointest Endosc (2005) 1.41
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases. Cancer (2012) 1.18
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol (2013) 1.14
Allopurinol in subjects with colorectal adenoma--letter. Cancer Prev Res (Phila) (2013) 1.07
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD. Nat Clin Pract Gastroenterol Hepatol (2007) 1.04
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut (2013) 1.02
Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study. Int J Cancer (2013) 1.02
Transluminal endoscopic step-up approach versus minimally invasive surgical step-up approach in patients with infected necrotising pancreatitis (TENSION trial): design and rationale of a randomised controlled multicenter trial [ISRCTN09186711]. BMC Gastroenterol (2013) 1.02
MR enteroclysis in refractory celiac disease: proposal and validation of a severity scoring system. Radiology (2011) 1.00
18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med (2006) 0.99
Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis (2011) 0.96
Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8β transdimer. J Immunol (2011) 0.95
Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease. PLoS One (2011) 0.94
Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands. Scand J Gastroenterol (2011) 0.94
Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism. Am J Gastroenterol (2007) 0.94
Neutrophil recruitment and barrier impairment in celiac disease: a genomic study. Clin Gastroenterol Hepatol (2007) 0.93
Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk. Am J Gastroenterol (2009) 0.91
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood (2008) 0.88
Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma. World J Gastroenterol (2007) 0.87
Video capsule endoscopy in patients with nonresponsive celiac disease. J Clin Gastroenterol (2013) 0.87
Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications. Acta Diabetol (2012) 0.87
Endoscopic N-butyl-2-cyanoacrylate (Histoacryl) obliteration of jejunal varices by using the double balloon enteroscope. Gastrointest Endosc (2007) 0.86
Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting. Dig Liver Dis (2010) 0.86
Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol (2006) 0.85
Ten years of infliximab for Crohn's disease: outcome in 469 patients from 2 tertiary referral centers. Inflamm Bowel Dis (2013) 0.85
The SPINK gene family and celiac disease susceptibility. Immunogenetics (2007) 0.84
Increased expression of the tight junction molecule claudin-18 A1 in both experimental colitis and ulcerative colitis. Inflamm Bowel Dis (2008) 0.83
Double balloon endoscopy in GI hemorrhage. Gastrointest Endosc (2007) 0.83
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT. Cancer Prev Res (Phila) (2011) 0.83
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.82
Temperature-controlled radiofrequency energy (SECCA) to the anal canal for the treatment of faecal incontinence offers moderate improvement. Eur J Gastroenterol Hepatol (2007) 0.82
Retrieval of a video capsule endoscope by using a double-balloon endoscope. Gastrointest Endosc (2005) 0.82
Pseudomelanosis coli and adenomatous polyps. J Gastrointestin Liver Dis (2011) 0.81
Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients. Clin Immunol (2005) 0.81
Acute experimental colitis and human chronic inflammatory diseases share expression of inflammation-related genes with conserved Ets2 binding sites. Inflamm Bowel Dis (2009) 0.81
Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn's disease: a pilot study. Drugs Today (Barc) (2005) 0.81
Anorectal complications and function in patients suffering from inflammatory bowel disease: a series of patients with long-term follow-up. Int J Colorectal Dis (2014) 0.81
Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations. Inflamm Bowel Dis (2010) 0.80
Allopurinol enhances the activity of hypoxanthine-guanine phosphoribosyltransferase in inflammatory bowel disease patients during low-dose thiopurine therapy: preliminary data of an ongoing series. Nucleosides Nucleotides Nucleic Acids (2011) 0.80
Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia. Hepatology (2008) 0.80
On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance. Curr Drug Metab (2009) 0.79
Rotavirus and coeliac autoimmunity among adults with non-specific gastrointestinal symptoms. Saudi Med J (2010) 0.79
Rac1 as a Potential Pharmacodynamic Biomarker for Thiopurine Therapy in Inflammatory Bowel Disease. Ther Drug Monit (2016) 0.78
Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patients. PLoS One (2013) 0.78
Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity. Liver Transpl (2005) 0.78
Hepatic steatosis in morbidly obese patients undergoing gastric bypass surgery: assessment with open-system 1H-MR spectroscopy. AJR Am J Roentgenol (2011) 0.78
Fructo-oligosaccharides and fibre in enteral nutrition has a beneficial influence on microbiota and gastrointestinal quality of life. Scand J Gastroenterol (2009) 0.77
Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment. J Crohns Colitis (2012) 0.77
Seroprevalence of celiac disease in patients with autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 0.77
The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease. Inflamm Bowel Dis (2016) 0.77
Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease. Ther Drug Monit (2015) 0.77
DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients. J Immunol (2011) 0.77
Paradoxical elevated thiopurine S-methyltransferase activity after pancytopenia during azathioprine therapy: potential influence of red blood cell age. Ther Drug Monit (2008) 0.77
Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication? Inflamm Bowel Dis (2017) 0.76
Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child? Expert Rev Gastroenterol Hepatol (2013) 0.76
Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis. BMC Gastroenterol (2011) 0.76
Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel Disease. Ther Drug Monit (2016) 0.76
Unintentional video capsule bronchoscopy. Eur J Gastroenterol Hepatol (2009) 0.76
[Guideline 'Coeliac disease and dermatitis herpetiformis']. Ned Tijdschr Geneeskd (2010) 0.76
Reply: To PMID 23333660. Clin Gastroenterol Hepatol (2013) 0.75
Post-colonoscopy massive air leakage with full body involvement: an impressive complication with uneventful recovery. Am J Gastroenterol (2009) 0.75
On the malignant potential of thiopurine therapy. Blood (2009) 0.75
Diarrhoea in a patient with metastatic melanoma: Ipilimumab ileocolitis treated with infliximab. World J Gastrointest Pharmacol Ther (2013) 0.75
The true ligand of the NOD2 receptor is peptidoglycan instead of lipopolysaccharide: a schematic representation of ligand-receptor interactions and NF-kappa B activation. Gastroenterology (2004) 0.75
Comment on: Leeds et al. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 2011;34:2158-2163. Diabetes Care (2012) 0.75
Oxidation-mediated DNA crosslinking contributes to toxicity of 6-thioguanine in human cells -- letter. Cancer Res (2013) 0.75
Diagnosing malabsorption in the intensive care unit. F1000 Med Rep (2010) 0.75
Low and adequately dosed 6-thioguanine: not so bad after all. Inflamm Bowel Dis (2008) 0.75
Small bowel: from sideline to center stage in gastroenterology. Dig Dis (2015) 0.75
Validation of Risk Factors for Fecal Incontinence in Patients With Crohn's Disease. Dis Colon Rectum (2017) 0.75
Small intestinal diverticulitis. Clin Gastroenterol Hepatol (2010) 0.75
Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids. Dig Dis (2017) 0.75
Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy. Inflamm Bowel Dis (2017) 0.75
Development of antibodies against humanized antitumor necrosis factor and loss of efficacy in a black spider monkey with inflammatory bowel disease. J Clin Rheumatol (2009) 0.75
The African Middle Eastern Society for Digestive Oncology mission against viral hepatitis and hepatocellular carcinoma. Arab J Gastroenterol (2013) 0.75
Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study. Ther Drug Monit (2017) 0.75
[Colorectal cancer screening in the Netherlands: which faecal occult blood test?]. Ned Tijdschr Geneeskd (2013) 0.75
Clinical experience and diagnostic algorithm of vulval Crohn's disease. Eur J Gastroenterol Hepatol (2017) 0.75
Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease Patients. Ther Drug Monit (2017) 0.75